Under the 2023 collaboration agreement, Assembly Bio will receive $35 million for Gilead’s exercise of the HSV program option
Adverse events were consistent with valbenazine’s established safety profile
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
Dr. Reddy's commits to achieving Net Zero greenhouse gas emissions across its value chain by FY 2045
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
Jaypirca is the first and only FDA-approved non-covalent (reversible) BTK inhibitor
The company is excluding data from the affected sites to maintain the study's integrity
Subscribe To Our Newsletter & Stay Updated
